Tildren 500 mg Lyophilisate for Solution for Infusion for Horses
Tildren 500 mg Lyophilisate for Solution for Infusion for Horses
Authorised
- Tiludronate disodium hemihydrate
Product identification
Medicine name:
TILDREN 500 mg Lyophilisat zur Herstellung einer Infusionslösung für Pferde
Tildren 500 mg Lyophilisate for Solution for Infusion for Horses
Active substance:
- Tiludronate disodium hemihydrate
Target species:
-
Horse
Route of administration:
-
Intravenous use
Product details
Active substance and strength:
-
Tiludronate disodium hemihydrate569.00/milligram(s)1.00Vial
Pharmaceutical form:
-
Lyophilisate for solution for infusion
Withdrawal period by route of administration:
-
Intravenous use
-
Horse
-
Meat and offal0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QM05BA05
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
United Kingdom (Northern Ireland)
Package description:
- A clear glass (type II) vial with chlorobutyl rubber closure secured by aluminium overseal with plastic flip-off cap within cardboard carton.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Audevard
Marketing authorisation date:
Manufacturing sites for batch release:
- Ceva Sante Animale
Responsible authority:
- The Veterinary Medicines Directorate
Authorisation number:
- Vm 44684/3000
Date of authorisation status change:
Reference member state:
-
Austria
Procedure number:
- AT/V/0026/001
Concerned member states:
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
How useful was this page?:
